A TrxR inhibiting gold(I) NHC complex induces apoptosis through ASK1-p38-MAPK signaling in pancreatic cancer cells
Cancer cells in the advanced stage show aberrant antioxidant capacity to detoxify excessive ROS resulting in the compensation for intrinsic oxidative stress and therapeutic resistance. PDAC is one of the most lethal cancers and often associated with a high accumulation of ROS. Recent studies identif...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
[2014]
|
| In: |
Molecular cancer
Year: 2014, Volume: 13, Issue: 1 |
| ISSN: | 1476-4598 |
| DOI: | 10.1186/1476-4598-13-221 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1476-4598-13-221 |
| Author Notes: | Xinlai Cheng, Pavlo Holenya, Suzan Can, Hamed Alborzinia, Riccardo Rubbiani, Ingo Ott and Stefan Wölfl |
| Summary: | Cancer cells in the advanced stage show aberrant antioxidant capacity to detoxify excessive ROS resulting in the compensation for intrinsic oxidative stress and therapeutic resistance. PDAC is one of the most lethal cancers and often associated with a high accumulation of ROS. Recent studies identified gold(I) NHC complexes as potent TrxR inhibitors suppressing cell growth in a wide spectrum of human malignant cell lines at the low micromolar concentration. However, the mechanism of action is not completely elucidated yet. |
|---|---|
| Item Description: | Autor Pavlo Holenya falsch als "Palvo Holenya" angegeben Gesehen am 07.08.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1476-4598 |
| DOI: | 10.1186/1476-4598-13-221 |